BMJ  2004;329:611-614 (11 September), doi:10.1136/bmj.329.7466.611

Clinical review

The journey: Parkinson's disease

Mary G Baker, president, European Parkinson's Disease Association1, Lizzie Graham, project manager2

1 Kailua, Mayford, Woking, Surrey GU22 0SH, 2 European Parkinson's Disease Association, Sevenoaks, Kent TN13 3NJ

Correspondence to: L Graham lizzie@epda.eu.com

The first 150 words of the full text of this article appear below.

Introduction

To receive a diagnosis of a chronic neurological illness is the beginning of a long journey into the unknown—a journey that may begin in hope, pass through periods of elation and frustration, and finally end in acceptance and resignation. We would like you to come with us part of the way along the journey of Parkinson's disease, seen from the point of view of those who are compelled to make it—the patients and their carers.

The map

When we begin any journey, we need a map. We need to pack and prepare for the journey. We need to know what to expect along the way. The telling of the diagnosis and the explanation of the disease and its treatment form just such a map. And, like the maps of the medieval world, the map of Parkinson's disease is full of unknown territories and nameless threats. Small wonder that the telling of the . . . [Full text of this article]

Where the map starts and ends

Travelling companions

What travellers need along the way

Travelling alone

Losing the path

Travellers' tales

Journey's end


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

What is it like to have Parkinson's disease?
BMJ 2004 329: 0. [Full Text]

Parkinson's disease: a journey
Kamran Abbasi
BMJ 2004 329: 0. [Extract] [Full Text] [PDF]

The patient's journey: travelling through life with a chronic illness
Peter Lapsley and Trish Groves
BMJ 2004 329: 582-583. [Extract] [Full Text] [PDF]

Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study
Tiia Anttila, Eeva-Liisa Helkala, Matti Viitanen, Ingemar Kåreholt, Laura Fratiglioni, Bengt Winblad, Hilkka Soininen, Jaakko Tuomilehto, Aulikki Nissinen, and Miia Kivipelto
BMJ 2004 329: 539. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • (2004). Hit parade. BMJ 329: 1051-1051 [Full text]  
  • Lapsley, P., Groves, T. (2004). The patient's journey: travelling through life with a chronic illness. BMJ 329: 582-583 [Full text]  

Rapid Responses:

Read all Rapid Responses

Melanins or melanin-like compounds as defense-line.
Friedrich Flachsbart
bmj.com, 13 Sep 2004 [Full text]
Patients’ voices in research into Parkinson’ Disease and massage therapy
Charlotte Paterson, et al.
bmj.com, 15 Sep 2004 [Full text]
Re: Melanins or melanin-like compounds as defense-line.
John P Heptonstall
bmj.com, 16 Sep 2004 [Full text]
Neuropsychiatric symptoms of Parkinson's Disease get forgotten
marion y gray
bmj.com, 16 Sep 2004 [Full text]
Re: Neuropsychiatric symptoms of Parkinson's Disease get forgotten
Nancy A Williams
bmj.com, 18 Dec 2004 [Full text]



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview